SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Wells Fargos downgrade to Underweight, citing worrying engagement trends and a potentially weaker original-content slate, is driving attention around Netflix. Traders are divided between concerns over content quality, competition and live-event costs, and bullish investors who view the move as analyst-driven and a buying opportunity, noting contrasting positive views from Evercore.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs planned Starship Flight 14 and NASAs selection of the company for a Falcon 9 StarBurst mission are driving attention, with traders debating whether launch momentum and expected index buying could fuel further gains. Bulls anticipate a squeeze around the launch and options activity, while bears focus on repeated launch delays, upcoming share unlocks, and the companys stretched valuation.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is under pressure after CEO Kelly Ortberg said stabilizing 737 MAX production is taking longer than expected because of wing-production constraints, while slower 787 ramp-up and muted expectations for a major China order added to concerns. Traders debated whether the selloff was an overreaction because full-year free-cash-flow guidance was maintained and MAX 10 certification, aircraft orders, and a potential labor agreement remain recovery catalysts.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Reports that AMD may raise chip prices by roughly 10% amid higher TSMC wafer costs are driving attention, with traders viewing the move as evidence of strong AI-chip demand and pass-through pricing power. The community is broadly bullish amid a wider semiconductor rebound, though some traders question the reports unconfirmed status and warn that AMDs valuation and extended rally could invite a pullback.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

The SECs five-year innovation exemption for trading tokenized U.S. stocks has focused attention on Securitize as a pure-play tokenization infrastructure provider. Traders are broadly bullish on the regulatory tailwind and tokenization growth, while some remain cautious about valuation, losses, and ongoing litigation.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

The Senates failure to advance the CLARITY Act has driven major attention to Circle, with traders debating its impact on stablecoin yield economics and regulatory prospects. The community is split between bearish views expecting further pressure on crypto stocks and bullish arguments that the setback is priced in, while Arcs launch and broader stablecoin adoption could support a rebound.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Attention centers on Berkshires post-Buffett leadership transition to Greg Abel and recent capital-allocation disclosures, including a larger Alphabet stake, housing investments and buybacks. Traders remain divided: many criticize the cash hoard, lack of dividends and persistent underperformance versus broader indexes, while bulls view Berkshires cash, Treasury holdings and operating businesses as defensive strength with future deployment potential.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Fresh Rothschild analyst coverage has put UAL in focus, with the firm maintaining a Buy rating while lowering its target amid a constructive outlook for domestic airline revenue. Traders are debating whether resilient premium and travel demand can offset elevated jet-fuel costs, which have raised concerns about capacity, margins, and guidance.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

FDA approval of Fayuvi, Ultragenyxs first treatment for Sanfilippo syndrome type A, is driving attention, with traders highlighting the new commercial product and accompanying Priority Review Voucher. The community is broadly bullish on the approval and potential revenue, though some debate the limited patient population, commercialization pace, cash burn, and the relatively muted share-price reaction.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Traders are focused on Uniswaps reported Robinhood integration and its role in tokenized-asset liquidity, alongside a fee-switch and buyback-and-burn narrative expected to support UNIs value capture. The community is broadly bullish after the sharp run, though some traders argue the catalyst is already priced in and are watching for an overbought pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A high-volume price breakout has drawn attention despite no confirmed company-specific announcement, with traders speculating about institutional accumulation, short covering, and upcoming Anktiva catalysts. Others attribute the move to broader biotech/XBI momentum and technical trading, cautioning that the rally may fade without follow-through or new data.

The move appears driven by unusually heavy trading and broader biotech momentum, with traders also focusing on reported institutional buying. No confirmed IBRX-specific company announcement clearly explains the move.

ImmunityBio (IBRX) Moves 7.0% Higher: Will This Strength Last?

ImmunityBio (IBRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

This Tiny Biotech Is Beating MRNA, IOVA And SLS — Here's How A Billionaire Fueled Its September Rally

Equity

The rally followed a Nant Capital-led financing worth up to $22.3 million, with $11.3 million raised at the initial close.

Biotech Midweek Pulse: XBI Loses Steam After Hot 2026 Run — Here Are The Stocks And Catalysts To Watch Next

Large-cap healthcare outperformed this week: XLV gained 1.4% through Tuesday, while XBI fell 1.4% and IBB declined 0.5%.

SLS, IBRX, IOVA In Focus Amid Big Pharma’s Early Cancer-Asset Hunt: J&J Flags M&A ‘Sweet Spot,’ Pfizer Eyes Phase 1-2 Deals 

J&J’s recent deals include the $3.05 billion Halda acquisition and $1 billion Firefly purchase, while Pfizer’s Innovent deal is worth up to $10.5 billion.

IBRX Stock Gains As Soon-Shiong’s Nant Capital Backs Second Cancer-Immunotherapy Bet  

PDS Biotech said it completed the initial close of a Nant Capital-led PIPE of up to $22.3 million and seated Soon-Shiong on its board — tying IBRX’s public face to a second immunotherapy platform.



SLS, IBRX Stocks Draw Investor Attention With Major Cancer Conferences And New Drug Data On Deck

ImmunityBio is attending major conferences in Seoul and New York, followed by several oncology events through November.

IBRX Stock Eyes Worst Week Since July: New Patent Eyes Broader Anktiva Use Ahead Of Lung Cancer Conference 

A new patent application covers using Anktiva to restore immune cells depleted by cancer treatments.

SLS, IBRX In Focus: Canadian Insurance Giant Manulife’s Unit Raises Stakes Ahead Of Key Cancer Catalysts 

Its IBRX stake jumped 27.5% to 243,678 shares worth $2.13 million, bringing both positions’ combined value to $2.86 million.

Qiagen (QGEN) Up 5.1% Since Last Earnings Report: Can It Continue?

Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is ImmunityBio (IBRX) Up 9.7% Since Last Earnings Report?

ImmunityBio (IBRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Neutral Sentiment

$SLS

$ONDS

$IBRX

$PYPL

Which of these trending stocks are you most bullish on right now - $SLS, $ONDS, $IBRX, or $PYPL?

Stocktwits

SELLAS Life Sciences Group Inc

Ondas Inc

PayPal Holdings Inc

Which of these trending stocks are you most bullish on right now - 

Microsoft Corp

Meta Platforms Inc

Alphabet Inc Class A

CoreWeave Inc

Stocktwits Polls

Traders are closely watching for high volume and price momentum to trigger a potential squeeze against heavily shorted shares.

Discussions center on recent SEC filings revealing significant stake increases by major firms like BlackRock and State Street.

Investors are debating the regulatory pathway for expanding label indications, focusing on Lymphopenia and prospective trial requirements.

Speculation is rising regarding deep integrations between ImmunityBio and PDSB following recent leadership moves and shared funding.

Feed

News

Sentiment

Earnings

Fundamentals

Info

IBRX News